Insider Trading April 1, 2026

Team Inc. Director Anthony R. Horton Makes $193K in Open-Market Purchases

Multiple Form 4 filings show Horton added 13,000 shares to his stake as the company balances recent EBITDA gains with cash and leverage concerns

By Priya Menon TISI
Team Inc. Director Anthony R. Horton Makes $193K in Open-Market Purchases
TISI

Anthony R. Horton, a director at Team Inc. (NYSE: TISI), disclosed two open-market purchases in a Form 4 filing: 10,000 shares at $14.44 on March 20, 2026, and 3,000 shares at $16.19 on March 30, 2026. The combined outlay of $192,970 increases his direct holdings to 22,082 shares. The filings arrive against a mixed backdrop of strong fourth-quarter 2025 results and analyst signals pointing to elevated leverage and rapid cash burn.

Key Points

  • Director Anthony R. Horton made two open-market purchases totaling 13,000 shares, spending $192,970.
  • After the purchases Horton directly owns 22,082 shares; the trades were disclosed on Form 4.
  • Contextual analysis highlights recent strong Q4 2025 results alongside concerns about leverage and cash burn, affecting investor focus in the industrials and machinery sectors.

Team Inc. director Anthony R. Horton has increased his direct ownership in the company through two open-market transactions disclosed in a Form 4 filing with the Securities and Exchange Commission.

The filing details two separate buys. On March 20, 2026, Horton acquired 10,000 shares at a price of $14.44 per share. He followed with a second purchase on March 30, 2026, when he bought an additional 3,000 shares at $16.19 per share. Both trades are recorded as open-market purchases and together represent a total expenditure of $192,970.

Following the transactions reported on the Form 4, Horton now directly holds 22,082 shares of Team Inc. The insider activity was reported while the stock traded at $15.69.

Market commentary included in the filing context notes an InvestingPro analysis that characterizes the shares as potentially overvalued at current levels. Those same InvestingPro materials flag that Team operates with a sizable debt load and is experiencing rapid cash burn. The InvestingPro service also references seven additional ProTips and a comprehensive Pro Research Report for subscribers seeking a deeper dive into Team Inc.'s financial position.

Separately, Team Inc. released fourth-quarter 2025 results that showed notable year-over-year growth across key financial metrics. The company did not issue explicit guidance for 2026 but emphasized continued focus on strategic growth initiatives and operational improvements under new chief executive Gary Hill. Investors reacted positively to the reported quarter despite the lack of forward-looking guidance, according to the contextual note included with the filings.

The company overview accompanying the insider disclosure highlights ongoing strategic efforts aimed at improving operational efficiency. The filing and related commentary stopped short of providing additional forward guidance, leaving market participants and analysts to monitor how management executes on the stated priorities in coming quarters.


What the filing shows

  • Horton purchased 10,000 shares at $14.44 on March 20, 2026.
  • Horton purchased 3,000 shares at $16.19 on March 30, 2026.
  • Total cash outlay for the two open-market purchases was $192,970.
  • Post-transactions direct ownership stands at 22,082 shares.

The Form 4 disclosure provides a clear, verifiable record of the trades. Beyond the raw transaction data, the surrounding context included in third-party analysis points to a juxtaposition: recent quarterly strength set against balance-sheet pressure and liquidity concerns. How Team Inc. balances those forces will be closely watched by investors and analysts in the industrials and machinery sectors.

Risks

  • Team Inc. carries a significant debt burden, a factor that may influence its financial flexibility - this primarily impacts credit and capital-intensive industrials sectors.
  • Rapid cash burn noted in third-party analysis raises short-term liquidity risk for the company - relevant to investors monitoring working capital and operational funding in machinery and manufacturing.
  • Absence of explicit guidance for 2026 leaves execution and outlook uncertain, meaning investors must rely on management's strategic initiatives and subsequent quarterly disclosures.

More from Insider Trading

Gevo COO Sells 129,797 Shares as Company Posts Strong Revenue Gain but Remains Unprofitable Apr 1, 2026 Dianthus Therapeutics Director Disposes of $47,985 in Shares, Exercises Options Apr 1, 2026 Dianthus CFO Sells $9.5M in Stock as Company Completes $719M Offering Apr 1, 2026 Processa Pharmaceuticals R&D President Buys 1,810 PCSA Shares; Company Reports Phase 2 Dosing Complete Apr 1, 2026 Processa Pharmaceuticals director buys $5,252 of PCSA stock, increases direct holding Apr 1, 2026